BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Alò GL, De Crescenzo F, Amato L, Cruciani F, Davoli M, Fulceri F, Minozzi S, Mitrova Z, Morgano GP, Nardocci F, Saulle R, Schünemann HJ, Scattoni ML; ISACA Guideline Working Group. Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis. Health Qual Life Outcomes 2021;19:33. [PMID: 33494757 DOI: 10.1186/s12955-021-01669-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 McConkey R, Samadi SA, Mahmoodizadeh A, Taggart L. The Use of Psychotropic Medication in Iranian Children with Developmental Disabilities. Int J Environ Res Public Health 2021;18:4120. [PMID: 33924699 DOI: 10.3390/ijerph18084120] [Reference Citation Analysis]
2 Thom RP, Pereira JA, Sipsock D, McDougle CJ. Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder. Curr Psychiatry Rep 2021;23:79. [PMID: 34643815 DOI: 10.1007/s11920-021-01292-2] [Reference Citation Analysis]
3 Nadeem MS, Hosawi S, Alshehri S, Ghoneim MM, Imam SS, Murtaza BN, Kazmi I. Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer's Disease. Biomolecules 2021;11:1635. [PMID: 34827633 DOI: 10.3390/biom11111635] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Meza N, Rees R, Escobar Liquitay CM, Franco JV, Sguassero Y, Williams K, Pringsheim T, Rojas V, Madrid E; Cochrane Developmental, Psychosocial and Learning Problems Group. Atypical antipsychotics for autism spectrum disorder: a network meta-analysis. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd014965] [Reference Citation Analysis]